Compass Therapeutics (CMPX) Shares Issued (2020 - 2026)

Compass Therapeutics' Shares Issued history runs 7 years deep, the most recent figure standing at $3.9 million for Q1 2026.

• In Q1 2026, Shares Issued changed N/A year-over-year to $3.9 million; the TTM figure through Mar 2026 stood at $5.1 million (up 899.81% YoY), while the FY2025 annual figure was $1.3 million, down 92.96% from the prior year.
• Shares Issued came in at $3.9 million for Q1 2026 at Compass Therapeutics, up from -$136.7 million in the prior quarter.
• In the past five years, Shares Issued ranged from a high of $138.0 million in Q3 2025 to a low of -$136.7 million in Q4 2025.
• A 5-year average of $11.4 million and a median of $3.1 million in 2023 frame the typical range for Shares Issued.
• Across the five-year window, Shares Issued tumbled 40.44% in 2022 and tumbled 95.98% in 2023, its largest moves.
• Compass Therapeutics' Shares Issued stood at $76.2 million in 2022, then sank by 95.98% to $3.1 million in 2023, then slumped by 83.26% to $513000.0 in 2024, then sank by 26751.85% to -$136.7 million in 2025, then surged by 102.82% to $3.9 million in 2026.
• According to Business Quant data, Shares Issued over the past three periods registered $3.9 million, -$136.7 million, and $138.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison